About CMC Biologics
CMC Biologics is a company based in Copenhagen (Denmark) founded in 2001 was acquired by AGC in December 2016.. The company has 1,264 employees as of March 31, 2024. CMC Biologics operates in a competitive market with competitors including KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others.
- Headquarter Copenhagen, Denmark
- Employees 1264 as on 31 Mar, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Agc Biologics A/S
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CMC Biologics
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2008 | Amount | Private Equity Round - CMC Biologics | Valuation |
investors |
|
| Jun, 2004 | Amount | Private Equity Round - CMC Biologics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CMC Biologics
CMC Biologics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include AGC, Monitor Clipper Partners and European Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Monitor Clipper Partners is engaged in middle-market private equity investments.
|
Founded Year | Domain | Location | |
|
Investment in life sciences companies is facilitated by EEP.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CMC Biologics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CMC Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cmc Biologics Comparisons
Competitors of CMC Biologics
CMC Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, Aldevron, Kemwell Biopharma, Eurogentec and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Integrated biologics development and manufacturing are provided as a CDMO.
|
|
| domain | founded_year | HQ Location |
Oligonucleotides, peptides, and antibodies are developed and manufactured by Eurogentec.
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Precision fermentation services for biopharma and food are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cmc Biologics
Frequently Asked Questions about CMC Biologics
When was CMC Biologics founded?
CMC Biologics was founded in 2001 and raised its 1st funding round 3 years after it was founded.
Where is CMC Biologics located?
CMC Biologics is headquartered in Copenhagen, Denmark.
How many employees does CMC Biologics have?
As of Mar 31, 2024, the latest employee count at CMC Biologics is 1,264.
What is the annual revenue of CMC Biologics?
Annual revenue of CMC Biologics is $55.44M as on Dec 31, 2014.
What does CMC Biologics do?
CMC Biologics provides biopharmaceutical contract manufacturing services. It offers microbial fermentation and mammalian cell culture based cGMP manufacturing services, such as process development and scale-up of protein processes; and production of biopharmaceuticals for pre-clinical, clinical trials, and market supply. CMC Biologics claims to be one of the few CDMOs that are capable of offering mammalian perfusion production services which include BioSEP, ATF and other perfusion technologies. CMC Biologics also has a proprietary CHEF1 Expression Platform for quicker and effective development through mammalian cell lines. The company also provides consultancy in facility design, quality, and regulatory issues; technology evaluation, analytical development and quality control services. The company has FDA MHRA approved manufacturing facilities (with both single-use and stainless steel bioreactors) in Copenhagen, Seattle and Berkeley and claims to have completed 120 projects right from preclinical supply to commercial production. The company was acquired by Japans AGC Asahi Glass in December 2016.
Who are the top competitors of CMC Biologics?
CMC Biologics's top competitors include KBI Biopharma, Aldevron and Ovagen.
Who are CMC Biologics's investors?
CMC Biologics has 4 investors. Key investors include AGC, Monitor Clipper Partners, European Equity Partners, and Innoven Partners.